Funding:
UC
DIABETES
This work was supported by NIH/NIDDK (DK127733). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Dr. Duru receives support from the NIH/NIDDK (R18DK122372, R01DK124503), NIH/NIA (P30AG021684-16), NIH/NHLBI (R25HL161609) and the CDC/NIDDK (U18DP006535, U18DP006534).Dr. Moin receives support from the NIH/NIDDK (R01DK124503, R18DK122372), NIDDK/CDC (U18DP006535), UCLA and the UC Office of the President (UCOP), as well as the Department of Veterans Affairs (QUE20-028, CSP2002 and CSPNODES).Dr. Han receives support from the Diabetes Research Center Pilot and Feasibility Award (P30 DK063491).Dr. Norris receives support from NIH Grants UL1TR000124, P30AG021684 and P50MD017366.Dr. Carol M. Mangione receives support from the University of California at Los Angeles (UCLA), Resource Centers for Minority Aging Research Center for Health Improvement of Minority Elderly under Trial statusClinician enrollment started December 2020, and patient enrollment started November 2021. We anticipate enrollment will be completed by September 2023.